Printer Friendly

T CELL SCIENCES NAMES JACQUELINE D. ARTHUR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

 T CELL SCIENCES NAMES JACQUELINE D. ARTHUR
 VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
 CAMBRIDGE, Mass., July 27 /PRNewswire/ -- T Cell Sciences, Inc. (NASDAQ: TCEL), today announced that Jacqueline D. Arthur has been named vice president and chief financial officer.
 Arthur joined T Cell Sciences from MIA Com, a leading independent supplier of microwave components, where she was vice president finance from 1990 to 1992. From 1986 to 1990, Arthur held senior management positiously as vice president, treasurer. Prior to joining Dennison, Arthur held several positions with The British Petroleum Co. from 1967-1986. She left British Petroleum as vice president finance of BP, North America. Arthur received a B.S. in economics and technology in 1972 from the City University, London, England, and is a chartered management accountant.
 "Jacqueline's management expertise in both finance and strategic planning makes her an important addition to the senior management team of T Cell Sciences," said Alan W. Tuck, president and chief executive officer of T Cell Sciences. "I am pleased that we have been able to attract someone of Jacqueline's caliber to be an important participant in building a successful biopharmaceutical company in the 1990s."
 Located in Cambridge, T Cell Sciences, Inc., is utilizing proprietary T cell and soluble receptor technology to develop pharmaceutical products to treat diseases of inflammation, autoimmunity and cancer. T Cell Diagnostics, an 84-percent owned subsidiary of T Cell Sciences, develops, manufactures and markets highly innovative diagnostic and research products around the world.
 -0- 7/27/92
 /CONTACT: Alan W. Tuck, president and chief executive officer, or Susan Primrose, manager, corporate development and communications, T Cell Sciences, 617-621-1400/
 (TCEL) CO: T Cell Sciences, Inc. ST: Massachusetts IN: MTC SU: PER


CN -- NE010 -- 3476 07/27/92 11:28 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 27, 1992
Words:289
Previous Article:ART'S-WAY FOURTH QUARTER AND 12-MONTH RESULTS
Next Article:DEERE & COMPANY ANNOUNCES FURTHER REDUCTIONS OF FISCAL 1992 PRODUCTION SCHEDULES
Topics:


Related Articles
T CELL SCIENCES NAMES ALAN W. TUCK PRESIDENT & CEO
T CELL SCIENCES ADDS THOMAS R. OSTERMUELLER TO BOARD OF DIRECTORS
ONCOGENE SCIENCE, INC. PROMOTES ARTHUR BRUSKIN TO VICE PRESIDENT, DRUG DISCOVERY, PHARMACEUTICAL DIVISION
PARACELSIAN (PRLN) NAMES KOCH CHIEF FINANCIAL OFFICER
NORMAN W. GORIN JOINS T CELL SCIENCES, INC. AS VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER
T CELL SCIENCES ANNOUNCES CHANGES IN MANAGEMENT
T CELL SCIENCES ANNOUNCES BOARD RESIGNATION

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters